Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 243,150 |
|
|||||
| News | - | ||||||
| Day High | 21.35 | Low High |
|||||
| Day Low | 21.21 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Fusion Pharmaceuticals Inc | FUSN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.035 | 0.16% | 21.285 | 13:59:46 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 21.25 | 21.21 | 21.35 | 21.25 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,641 | 243,150 | $ 21.25 | $ 5,165,838 | - | 2.31 - 21.55 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:59:46 | 100 | $ 21.285 | USD |
Fusion Pharmaceuticals (FUSN) Options Flow Summary
Fusion Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.47B | 68.99M | - | 1.46M | -87.61M | -1.27 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Fusion Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FUSN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 21.35 | 21.40 | 21.18 | 21.27 | 522,169 | -0.065 | -0.30% |
| 1 Month | 21.18 | 21.55 | 20.97 | 21.30 | 1,539,927 | 0.105 | 0.50% |
| 3 Months | 10.70 | 21.55 | 9.09 | 18.00 | 2,281,125 | 10.59 | 98.93% |
| 6 Months | 4.64 | 21.55 | 3.75 | 15.24 | 1,449,572 | 16.65 | 358.73% |
| 1 Year | 4.05 | 21.55 | 2.31 | 14.50 | 775,648 | 17.24 | 425.56% |
| 3 Years | 8.45 | 21.55 | 1.98 | 12.62 | 317,777 | 12.84 | 151.89% |
| 5 Years | 18.50 | 21.55 | 1.98 | 12.75 | 269,123 | 2.79 | 15.05% |
Fusion Pharmaceuticals Description
| Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing alpha therapeutics for curing cancer. It develops Targeted Alpha Therapies (TAT) together with its proprietary Fast-Clear linker technology. The firm's lead product candidate comprises FPI-1434, a monotherapy for the treatment of a variety of cancers; FPI-1966, for the treatment of head and neck and bladder cancers; and FPI-2059 among others. |
